175 related articles for article (PubMed ID: 31143183)
1. Proteomic Profiling Unravels a Key Role of Specific Macrophage Subtypes in Sporadic Inclusion Body Myositis.
Roos A; Preusse C; Hathazi D; Goebel HH; Stenzel W
Front Immunol; 2019; 10():1040. PubMed ID: 31143183
[TBL] [Abstract][Full Text] [Related]
2. The immune system in sporadic inclusion body myositis patients is not compromised by blood-flow restricted exercise training.
Jensen KY; Jacobsen M; Schrøder HD; Aagaard P; Nielsen JL; Jørgensen AN; Boyle E; Bech RD; Rosmark S; Diederichsen LP; Frandsen U
Arthritis Res Ther; 2019 Dec; 21(1):293. PubMed ID: 31852482
[TBL] [Abstract][Full Text] [Related]
3. A subpopulation of CD163-positive macrophages is classically activated in psoriasis.
Fuentes-Duculan J; Suárez-Fariñas M; Zaba LC; Nograles KE; Pierson KC; Mitsui H; Pensabene CA; Kzhyshkowska J; Krueger JG; Lowes MA
J Invest Dermatol; 2010 Oct; 130(10):2412-22. PubMed ID: 20555352
[TBL] [Abstract][Full Text] [Related]
4. Upregulated inducible co-stimulator (ICOS) and ICOS-ligand in inclusion body myositis muscle: significance for CD8+ T cell cytotoxicity.
Schmidt J; Rakocevic G; Raju R; Dalakas MC
Brain; 2004 May; 127(Pt 5):1182-90. PubMed ID: 15047591
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated macrophages in oral premalignant lesions coexpress CD163 and STAT1 in a Th1-dominated microenvironment.
Mori K; Haraguchi S; Hiori M; Shimada J; Ohmori Y
BMC Cancer; 2015 Aug; 15():573. PubMed ID: 26242181
[TBL] [Abstract][Full Text] [Related]
6. Proteomics of rimmed vacuoles define new risk allele in inclusion body myositis.
Güttsches AK; Brady S; Krause K; Maerkens A; Uszkoreit J; Eisenacher M; Schreiner A; Galozzi S; Mertens-Rill J; Tegenthoff M; Holton JL; Harms MB; Lloyd TE; Vorgerd M; Weihl CC; Marcus K; Kley RA
Ann Neurol; 2017 Feb; 81(2):227-239. PubMed ID: 28009083
[TBL] [Abstract][Full Text] [Related]
7. PD1 pathway in immune-mediated myopathies: Pathogenesis of dysfunctional T cells revisited.
Knauss S; Preusse C; Allenbach Y; Leonard-Louis S; Touat M; Fischer N; Radbruch H; Mothes R; Matyash V; Böhmerle W; Endres M; Goebel HH; Benveniste O; Stenzel W
Neurol Neuroimmunol Neuroinflamm; 2019 May; 6(3):e558. PubMed ID: 31044146
[TBL] [Abstract][Full Text] [Related]
8. Gain and loss of extracellular molecules in sporadic inclusion body myositis and polymyositis--a proteomics-based study.
Doppler K; Lindner A; Schütz W; Schütz M; Bornemann A
Brain Pathol; 2012 Jan; 22(1):32-40. PubMed ID: 21672074
[TBL] [Abstract][Full Text] [Related]
9. CD163 expression defines specific, IRF8-dependent, immune-modulatory macrophages in the bone marrow.
Fischer-Riepe L; Daber N; Schulte-Schrepping J; Véras De Carvalho BC; Russo A; Pohlen M; Fischer J; Chasan AI; Wolf M; Ulas T; Glander S; Schulz C; Skryabin B; Wollbrink Dipl-Ing A; Steingraeber N; Stremmel C; Koehle M; Gärtner F; Vettorazzi S; Holzinger D; Gross J; Rosenbauer F; Stoll M; Niemann S; Tuckermann J; Schultze JL; Roth J; Barczyk-Kahlert K
J Allergy Clin Immunol; 2020 Nov; 146(5):1137-1151. PubMed ID: 32199911
[TBL] [Abstract][Full Text] [Related]
10. MHC class II compartment, endocytosis and phagocytic activity of macrophages and putative dendritic cells isolated from normal tissues rich in synovium.
Moghaddami M; Mayrhofer G; Cleland LG
Int Immunol; 2005 Aug; 17(8):1117-30. PubMed ID: 16027140
[TBL] [Abstract][Full Text] [Related]
11. Human β-defensin-3 correlates with muscle fibre degeneration in idiopathic inflammatory myopathies.
Güttsches AK; Jacobsen F; Theiss C; Rittig A; Rehimi R; Kley RA; Vorgerd M; Steinstraesser L
Innate Immun; 2014 Jan; 20(1):49-60. PubMed ID: 23608825
[TBL] [Abstract][Full Text] [Related]
12. Beta-amyloid is a substrate of autophagy in sporadic inclusion body myositis.
Lünemann JD; Schmidt J; Schmid D; Barthel K; Wrede A; Dalakas MC; Münz C
Ann Neurol; 2007 May; 61(5):476-83. PubMed ID: 17469125
[TBL] [Abstract][Full Text] [Related]
13. Distribution of the NF-kappaB complex in the inflammatory exudates characterizing the idiopathic inflammatory myopathies.
Creus KK; De Paepe B; Werbrouck BF; Vervaet V; Weis J; De Bleecker JL
Ann N Y Acad Sci; 2009 Sep; 1173():370-7. PubMed ID: 19758175
[TBL] [Abstract][Full Text] [Related]
14. Basement membrane remodelling and segmental fibrosis in sporadic inclusion body myositis.
Doppler K; Mittelbronn M; Lindner A; Bornemann A
Neuromuscul Disord; 2009 Jun; 19(6):406-11. PubMed ID: 19473842
[TBL] [Abstract][Full Text] [Related]
15. MHC II+ CD45+ cells from synovium-rich tissues of normal rats: phenotype, comparison with macrophage and dendritic cell lineages and differentiation into mature dendritic cells in vitro.
Moghaddami M; Cleland LG; Mayrhofer G
Int Immunol; 2005 Aug; 17(8):1103-15. PubMed ID: 16030130
[TBL] [Abstract][Full Text] [Related]
16. Alternatively activated macrophages in the pathogenesis of chronic kidney allograft injury.
Ikezumi Y; Suzuki T; Yamada T; Hasegawa H; Kaneko U; Hara M; Yanagihara T; Nikolic-Paterson DJ; Saitoh A
Pediatr Nephrol; 2015 Jun; 30(6):1007-17. PubMed ID: 25487670
[TBL] [Abstract][Full Text] [Related]
17. AM-3K, an anti-macrophage antibody, recognizes CD163, a molecule associated with an anti-inflammatory macrophage phenotype.
Komohara Y; Hirahara J; Horikawa T; Kawamura K; Kiyota E; Sakashita N; Araki N; Takeya M
J Histochem Cytochem; 2006 Jul; 54(7):763-71. PubMed ID: 16517975
[TBL] [Abstract][Full Text] [Related]
18. Participation of functionally different macrophage populations and monocyte chemoattractant protein-1 in early stages of thioacetamide-induced rat hepatic injury.
Mori Y; Izawa T; Takenaka S; Kuwamura M; Yamate J
Toxicol Pathol; 2009 Jun; 37(4):463-73. PubMed ID: 19389872
[TBL] [Abstract][Full Text] [Related]
19. Effects of sporadic inclusion body myositis on skeletal muscle fibre type specific morphology and markers of regeneration and inflammation.
Jensen KY; Nielsen JL; Aagaard P; Jacobsen M; Jørgensen AN; Bech RD; Frandsen U; Diederichsen LP; Schrøder HD
Rheumatol Int; 2024 Jun; 44(6):1077-1087. PubMed ID: 38581449
[TBL] [Abstract][Full Text] [Related]
20. Tumor-promoting macrophages induce the expression of the macrophage-specific receptor CD163 in malignant cells.
Maniecki MB; Etzerodt A; Ulhøi BP; Steiniche T; Borre M; Dyrskjøt L; Orntoft TF; Moestrup SK; Møller HJ
Int J Cancer; 2012 Nov; 131(10):2320-31. PubMed ID: 22362417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
